CTT Pharmaceutical (PK) Stock Price

0.001 (1.96%)


52 Week Range


Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CTT Pharmaceutical Holdings Inc (PK) CTTH OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.001 1.96% 0.052 15:29:56
Open Price Low Price High Price Close Price Prev Close
0.054 0.052 0.054 0.052 0.051
Bid Price Ask Price Spread News
0.051 0.066 0.015 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3 12,000 $ 0.054 $ 648 - 0.0301 - 0.26
Last Trade Time Type Quantity Stock Price Currency
13:21:41 4,000 $ 0.052 USD


Draw Mode:

CTT Pharmaceutical Holdings Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.47M 47.57M 29.67M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
8.87k $ - - - -

more financials information »

CTT Pharmaceutical (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0550.059450.0510.05111278,885-0.003-5.45%
1 Month0.06750.07810.046550.05223218,214-0.0155-22.96%
3 Months0.09740.09750.040.056813524,946-0.0454-46.61%
6 Months0.06450.170.040.086374227,559-0.0125-19.38%
1 Year0.070.260.03010.078605424,246-0.018-25.71%
3 Years0.831.950.03010.481984536,773-0.778-93.73%
5 Years0.0352.170.01260.544471433,6290.01748.57%

CTT Pharmaceutical (PK) Description

CTTH's principal asset is a unique and novel patented drug delivery technology, an orally administered, fast dissolving thin film (the "Wafer"). This technology platform will target both the human and veterinarian (pet) markets for treatment of many diseases. The Company believes that its Wafer technology will be one of the first to gain use in major markets such as pain management. The Oral Thin Film (Wafer) formulation is protected by several Canadian and U.S. patents. Aurora Cannabis Inc. has made a strategic investment in in CTT by way of a non-brokered private placement in the form of a US$1 million 5% convertible debenture. The agreement includes an issuance of warrants enabling Aurora to increase its ownership to 42.5%.

Your Recent History
CTT Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.